Moreover, wound-healing assays suggested that knockdown of ALOX12 inhibited the migration of CRC cells (Figures 6A–D), and transwell assays, including migration and invasion assays, indicated that the migratory ability and invasive ability were reduced when ALOX12 was depleted (Figures 6E–J). This evidence concerns the gene ALOX12 and colorectal carcinoma.